Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001452884 | SCV001656561 | likely benign | Noonan syndrome 9 | 2024-12-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001532902 | SCV001748693 | likely benign | not specified | 2021-07-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001452884 | SCV002762974 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV003372906 | SCV004096331 | likely benign | Cardiovascular phenotype | 2023-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003884788 | SCV004703332 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | SOS2: BP4, BP7 |